Clinical Trials Logo

Clinical Trial Summary

The inhibitory effect of low dose GLP-1 is investigated on prandial motility of the stomach, duodenum and jejunum in vivo in humans. Supplementary in vitro studies on the mechanism of action of the GLP-1 inhibition of motility as carried out on muscle strips from the upper gastrointestinal tract in man.


Clinical Trial Description

Twelve healthy volunteers will undergo antroduodenojejunal manometry. Baseline recording with infusion of saline for 1 hour is compared with infusion of GLP-1 0.7 and 1.2 pmol per kg minute for another 1 hour. Plasma GLP-1 and GLP-2 is measured by RIA. Responses to GLP-1 will be measured after food intake as prandial response to GLP-1. The outcome will be evaluated as change in motility index from baseline to meal-stimulated conditions and during influence of GLP-1. Further in vitro studies of gastrointestinal muscle strips, precontracted with bethanechol or electric field stimulation, are planned to investigate the response to GLP-1 or GLP-1 analogue ROSE-010. GLP-1 and GLP-2 receptor immunoreactivity is localized by immunohistochemistry. Receptor mediated mechanisms are studied with GLP-1 receptor blocker exendin(9-39)amide, nitro-monomethyl arginine to block nitric oxide synthase and tetrodotoxin to block sodium channels and nerve conduction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02731664
Study type Interventional
Source Uppsala University
Contact
Status Completed
Phase Phase 1
Start date September 2012
Completion date August 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05936112 - Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study N/A
Completed NCT02565355 - Targeted Food Elimination for Treatment of Functional Gastrointestinal Diseases in Children N/A
Completed NCT02657668 - Emotion Focused Therapy in Irritable Bowel Syndrome Patients N/A
Recruiting NCT06205446 - Application of Diaphragmatic Breathing in Patients With Disorders of Gut-brain Interaction N/A
Recruiting NCT05718960 - Traditional Dietary Advice Versus Reassurance-alone in Postprandial Functional Dyspepsia N/A
Terminated NCT04247100 - A Study of Randomized Sham-control Auricular TENS Unit Stimulation in Pediatric Functional Gastrointestinal Disorders N/A
Recruiting NCT03625674 - Impact of Stigma on Compliance to Medication in Functional Dyspepsia N/A
Completed NCT03252743 - ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study. N/A
Recruiting NCT05832528 - Low FODMAP Diet in FD (PDS) N/A
Completed NCT02936713 - Effect of Controlled Diet Combined With a Fermented Milk Product on Gas-related Symptoms N/A
Terminated NCT01712412 - Phase 2a Study of IW-9179 to Treat Functional Dyspepsia Phase 2
Completed NCT00564525 - Study of Medication for Functional Abdominal Pain in Children Phase 4
Recruiting NCT05987813 - Transcutaneous Electric Nerve Stimulation (TENS) for Vagal Modulation N/A
Completed NCT04155801 - A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal Disturbances N/A
Recruiting NCT05880199 - BSGM to Evaluate Patients With GI Symptoms
Recruiting NCT04625881 - Effects of an Apple Derived Fibre Supplement on Constipation Phase 3
Completed NCT03608735 - Prevalence of Functional Gastrointestinal Disorders (FGIDs), Related Signs and Symptoms in Infants/Toddlers in Thailand
Recruiting NCT04773158 - Systematic Pediatric Assessment of Rome Criteria N/A
Completed NCT02306369 - Internet-delivered CBT for Irritable Bowel Syndrome in Adolescents N/A
Recruiting NCT05486585 - i-CBT Functional Gastrointestinal Disorders in Youth: the Impact of Negative Illness Understanding and Parental Illness Worries N/A